If you made any changes in Pure these will be visible here soon.

Research Output 1983 2019

  • 4569 Citations
  • 32 h-Index
  • 95 Article
  • 3 Review article
Filter
Article
1998
90 Citations (Scopus)

Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome

Nadali, G., Tavecchia, L., Zanolin, E., Bonfante, V., Viviani, S., Camerini, E., Musto, P., Di Renzo, N., Carotenuto, M., Chilosi, M., Krampera, M. & Pizzolo, G., Apr 15 1998, In : Blood. 91, 8, p. 3011-3016 6 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Molecules
Disease-Free Survival
Serum
Confidence Intervals
27 Citations (Scopus)

Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: Outcome and clinical implications

Viviani, S., Camerini, E., Bonfante, V., Santoro, A., Balzarotti, M., Fornier, M., Devizzi, L., Verderio, P., Valagussa, P. & Bonadonna, G., 1998, In : British Journal of Cancer. 77, 6, p. 992-997 6 p.

Research output: Contribution to journalArticle

Interleukin-2 Receptors
Hodgkin Disease
Healthy Volunteers
Serum
Recurrence
1997
52 Citations (Scopus)

Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease

Devizzi, L., Maffioli, L., Bonfante, V., Viviani, S., Balzarini, L., Gasparini, M., Valagussa, P., Bombardieri, E., Santoro, A. & Bonadonna, G., 1997, In : Annals of Oncology. 8, SUPPL. 1

Research output: Contribution to journalArticle

Mediastinal Diseases
Gallium
Hodgkin Disease
Radionuclide Imaging
Magnetic Resonance Spectroscopy

Hodgkin's disease failures: Incorporating radiotherapy and high-dose treatment [2] (multiple letters)

Prince, H. M., Wirth, A., Bonfante, V., Viviani, S. & Bonadonna, G., 1997, In : Journal of Clinical Oncology. 15, 8, p. 3022-3023 2 p.

Research output: Contribution to journalArticle

24 Citations (Scopus)

Late pulmonary toxicity after treatment for Hodgkin's disease

Villani, F., De Maria, P., Bonfante, V., Viviani, S., Laffranchi, A., Dell'Oca, I., Dirusso, A. & Zanini, M., Nov 1997, In : Anticancer Research. 17, 6 D, p. 4739-4742 4 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Lung
Total Lung Capacity
Radiotherapy
Vital Capacity
152 Citations (Scopus)

Outcome of patients with Hodgkin's disease failing after primary MOPP- ABVD

Bonfante, V., Santoro, A., Viviani, S., Devizzi, L., Balzarotti, M., Soncini, F., Zanini, M., Valagussa, P. & Bonadonna, G., Feb 1997, In : Journal of Clinical Oncology. 15, 2, p. 528-534 7 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Recurrence
Salvage Therapy
Drug Therapy
Therapeutics
1996
158 Citations (Scopus)

Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: Ten-year results

Viviani, S., Bonadonna, G., Santoro, A., Bonfante, V., Zanini, M., Devizzi, L., Soncini, F. & Valagussa, P., May 1996, In : Journal of Clinical Oncology. 14, 5, p. 1421-1430 10 p.

Research output: Contribution to journalArticle

Procarbazine
Mechlorethamine
Dacarbazine
Vinblastine
Bleomycin

Lack of carboplatin activity in malignant lymphomas [3]

Balzarotti, M., Tondini, C., Bonfante, V., Devizzi, L., Viviani, S., Fornier, M. & Santoro, A., Dec 1996, In : European Journal of Cancer. 32, 13, p. 2370-2371 2 p.

Research output: Contribution to journalArticle

32 Citations (Scopus)

Vinorelbine: A new promising drug in Hodgkin's disease

Devizzi, L., Santoro, A., Bonfante, V., Viviani, S. & Bonadonna, G., 1996, In : Leukemia and Lymphoma. 22, 5-6, p. 409-414 6 p.

Research output: Contribution to journalArticle

1994
9 Citations (Scopus)

Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (Prognostic role of stage)

Zanini, M., Viviani, S., Santoro, A., Soncini, F., Bonfante, V., Devizzi, L., Villan, F., Castellani, M. R., Negretti, E., Zucali, R., Rilke, F. & Banfi, A., Nov 15 1994, In : International Journal of Radiation Oncology Biology Physics. 30, 4, p. 813-819 7 p.

Research output: Contribution to journalArticle

Hodgkin Disease
radiation therapy
Radiotherapy
chemotherapy
Second Primary Neoplasms
33 Citations (Scopus)

Multiple defects of T helper cell function in newly diagnosed patients with Hodgkin's disease

Clerici, M., Ferrario, E., Trabattoni, D., Viviani, S., Bonfanti, V., Venzon, D. J., Clerici, E., Shearer, G. M. & Villa, M. L., 1994, In : European Journal of Cancer. 30, 10, p. 1464-1470 7 p.

Research output: Contribution to journalArticle

Helper-Inducer T-Lymphocytes
Hodgkin Disease
Interleukin-2
Phytohemagglutinins
Isoantigens
67 Citations (Scopus)

Vinorelbine: An active drug for the management of patients with heavily pretreated Hodgkin's disease

Devizzi, L., Santoro, A., Bonfante, V., Viviani, S., Balzarini, L., Valagussa, P. & Bonadonna, G., Nov 1994, In : Annals of Oncology. 5, 9, p. 817-820 4 p.

Research output: Contribution to journalArticle

Hodgkin's Disease
Hodgkin Disease
Drugs
Toxicity
Alkaloids
1993
1 Citation (Scopus)

Chronic effects of subuctaneous interleukin-2 therapy on soluble interleukin-2 receptors in advanced small cell lung cancer

Viviani, S., Salvini, P. M., Bidoli, P., Camerini, E., Spinazze, S., Arienti, F., Rivoltini, L. & Motta, V., 1993, In : International Journal of Biological Markers. 8, 1, p. 21-24 4 p.

Research output: Contribution to journalArticle

Interleukin-2 Receptors
Small Cell Lung Carcinoma
Interleukin-2
Cells
Therapeutics
26 Citations (Scopus)

Early stage Hodgkin's disease: Ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP

Bonfante, V., Santoro, A., Viviani, S., Zucali, R., Devizzi, L., Zanini, M., Tess, J. D. T., Valagussa, P., Banfi, A. & Bonadonna, G., 1993, In : European Journal of Cancer. 29, 1, p. 24-29 6 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Radiotherapy
Vinblastine
Bleomycin
Procarbazine
1992
31 Citations (Scopus)

ABVD in the treatment of Hodgkin's disease

Bonfante, V., Santoro, A., Viviani, S., Valagussa, P. & Bonadonna, G., 1992, In : Seminars in Oncology. 19, 2 SUPPL. 5, p. 38-45 8 p.

Research output: Contribution to journalArticle

Bleomycin
Hodgkin Disease
Procarbazine
Mechlorethamine
Vincristine
12 Citations (Scopus)

Normalization of the light/dark rhythm of melatonin after prolonged subcutaneous administration of interleukin-2 in advanced small cell lung cancer patients

Viviani, S., Bidoli, P., Spinazze, S., Rovelli, F. & Lissoni, P., 1992, In : Journal of Pineal Research. 12, 3, p. 114-117 4 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Melatonin
Interleukin-2
Light
Neoplasms
1991
25 Citations (Scopus)

Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: The Milan experience

Viviani, S., Bonadonna, G., Santoro, A., Zanini, M., Zucali, R., Negretti, E. & Valagussa, P., 1991, In : Annals of Oncology. 2, SUPPL. 2, p. 55-62 8 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Drug Therapy
Radiotherapy
Survival
Tumor Burden
8 Citations (Scopus)

Effect of prolonged subcutaneous administration of interleukin-2 on the circadian rhythms of cortisol and beta-endorphin in advanced small cell lung cancer patients

Spinazze, S., Viviani, S., Bidoli, P., Rovelli, F., Palmer, P., Franks, C. R., Arienti, F., Rivoltini, L. & Parmiani, G., 1991, In : Tumori. 77, 6, p. 496-499 4 p.

Research output: Contribution to journalArticle

beta-Endorphin
Small Cell Lung Carcinoma
Circadian Rhythm
Interleukin-2
Hydrocortisone
52 Citations (Scopus)

Primary and salvage chemotherapy in advanced Hodgkin's disease: The Milan Cancer Institute experience

Bonadonna, G., Santoro, A., Gianni, A. M., Viviani, S., Siena, S., Bregni, M., Zucali, R., Lombardi, F., Bonfante, V., Gianni, L. & Valagussa, P., 1991, In : Annals of Oncology. 2, SUPPL. 1, p. 9-16 8 p.

Research output: Contribution to journalArticle

Anthracyclines
Hodgkin Disease
Procarbazine
Drug Therapy
Mechlorethamine
111 Citations (Scopus)

Testicular dysfunction in Hodgkin's disease before and after treatment

Viviani, S., Ragni, G., Santoro, A., Perotti, L., Caccamo, E., Negretti, E., Valagussa, P. & Bonadonna, G., 1991, In : European Journal of Cancer and Clinical Oncology. 27, 11, p. 1389-1392 4 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Follicle Stimulating Hormone
Semen
Prolactin
Therapeutics
1990
26 Citations (Scopus)

Analysis of t helper and suppressor lymphocyte subsets in relation to the clinical stage of solid neoplasms

Tancini, G., Bar Ni, S., Rescaldani, R., Fiorelli, G., Viviani, S. & Lissoni, P., 1990, In : Oncology. 47, 5, p. 381-384 4 p.

Research output: Contribution to journalArticle

Lymphocyte Subsets
CD4-CD8 Ratio
Neoplasms
Neoplasm Metastasis
T-Lymphocyte Subsets
17 Citations (Scopus)

Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukaemia (t-ANLL)

Sozzi, G., Miozzo, M., Orazi, A., Calderone, C., Castellano, M., Viviani, S., Santoro, A., Pierotti, M. A. & Della Porta, G., 1990, In : British Journal of Cancer. 61, 3, p. 425-428 4 p.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Cytogenetics
Monosomy
Chromosome Aberrations
15 Citations (Scopus)

Preliminary studies on melatonin in the treatment of myelodysplastic syndromes following cancer chemotherapy

Viviani, S., Negretti, E., Orazi, A., Sozzi, G., Santoro, A., Lissoni, P., Esposti, G. & Fraschini, F., 1990, In : Journal of Pineal Research. 8, 4, p. 347-354 8 p.

Research output: Contribution to journalArticle

60 Citations (Scopus)

Salvage chemotherapy in Hodgkin's disease: Results in patients relapsing more than twelve months after first complete remission

Viviani, S., Santoro, A., Negretti, E., Bonfante, V., Valagussa, P. & Bonadonna, G., 1990, In : Annals of Oncology. 1, 2, p. 123-127 5 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Drug Therapy
Recurrence
Salvage Therapy
Survival
73 Citations (Scopus)

The biological significance of soluble interleukin-2 receptors in solid tumors

Lissoni, P., Barni, S., Rovelli, F., Viviani, S., Maestroni, G. J. M., Conti, A. & Tancini, G., 1990, In : European Journal of Cancer and Clinical Oncology. 26, 1, p. 33-36 4 p.

Research output: Contribution to journalArticle

Interleukin-2 Receptors
Neoplasms
Small Cell Lung Carcinoma
Immunoenzyme Techniques
Cervix Uteri
1989
2 Citations (Scopus)

Alterations of pineal gland and of T lymphocyte subsets in metastatic cancer patients: preliminary results

Lissoni, P., Tancini, G., Barni, S., Viviani, S., Archili Cattaneo, C. G. & Fiorelli, G., 1989, In : Journal of Biological Regulators and Homeostatic Agents. 3, 4, p. 181-183 3 p.

Research output: Contribution to journalArticle

pineal body
Pineal Gland
T-Lymphocyte Subsets
melatonin
Melatonin
4 Citations (Scopus)

Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasms

Lissoni, P., Barni, S., Tancini, G., Viviani, S., Rovelli, F., Resc aldani, R. & Fiorelli, G., 1989, In : Journal of Biological Regulators and Homeostatic Agents. 3, 3, p. 131-133 3 p.

Research output: Contribution to journalArticle

CD4-CD8 Ratio
Interleukin-2 Receptors
interleukin-2
drug therapy
Drug Therapy
13 Citations (Scopus)

Hodgkin's disease: the Milan Cancer Institute experience with MOPP and ABVD.

Bonadonna, G., Valagussa, P., Santoro, A., Viviani, S., Bonfante, V. & Banfi, A., 1989, In : Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 117, p. 169-174 6 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Radiotherapy
Poisons
Infertility
Neoplasms
14 Citations (Scopus)

Serum levels of interleukin-2 in cancer patients: Preliminary considerations

Lissoni, P., Viviani, S., Santoro, A., Barni, S. & Tancini, G., 1989, In : International Journal of Biological Markers. 4, 4, p. 203-206 4 p.

Research output: Contribution to journalArticle

Interleukin-2
Tumors
Serum
Interleukin-2 Receptors
Neoplasms
1988
7 Citations (Scopus)

Morphologic, immunologic, and cytogenetic characteristics of secondary acute unclassifiable leukemia in Hodgkin's disease

Orazi, A., Cattoretti, G., Sozzi, G., Miozzo, M., Polli, N., Delia, D., Viviani, S., Negretti, E., Della Porta, G. & Rilke, F., 1988, In : Tumori. 74, 4, p. 439-450 12 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Cytogenetics
Leukemia
Blast Crisis
Cytogenetic Analysis
19 Citations (Scopus)

Treatment strategies for Hodgkin's disease.

Bonadonna, G., Santoro, A., Viviani, S. & Valagussa, P., Apr 1988, In : Seminars in Hematology. 25, 2 Suppl 2, p. 51-57 7 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Morbidity
Drug Therapy
Therapeutics
Radiotherapy
1987
289 Citations (Scopus)

Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: Superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy

Santoro, A., Bonadonna, G., Valagussa, P., Zucali, R., Viviani, S., Villani, F., Pagnoni, A. M., Bonfante, V., Musumeci, R. & Crippa, F., 1987, In : Journal of Clinical Oncology. 5, 1, p. 27-37 11 p.

Research output: Contribution to journalArticle

Procarbazine
Mechlorethamine
Dacarbazine
Vinblastine
Bleomycin
20 Citations (Scopus)

The clinical significance of melatonin serum determination in oncological patients and its correlations with GH and PRL blood levels

Lissoni, P., Bastone, A., Sala, R., Mauri, R., Rovelli, F., Viviani, S., Bajetta, E., Esposti, D., Esposti, G., Di Bella, L. & Fraschini, F., 1987, In : European Journal of Cancer and Clinical Oncology. 23, 7, p. 949-957 9 p.

Research output: Contribution to journalArticle

Melatonin
Serum
Neoplasm Metastasis
Breast Neoplasms
Neoplasms
1986
27 Citations (Scopus)

A clinical study of the pineal gland activity in oncologic patients

Lissoni, P., Viviani, S., Bajetta, E., Buzzoni, R., Barreca, A., Mauri, R., Resentini, M., Morabito, F., Esposti, D. & Esposti, G., 1986, In : Cancer. 57, 4, p. 837-842 6 p.

Research output: Contribution to journalArticle

Pineal Gland
Melatonin
Neoplasms
Light
Serum
65 Citations (Scopus)

CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease

Santoro, A., Viviani, S., Valagussa, P., Bonfante, V. & Bonadonna, G., 1986, In : Seminars in Oncology. 13, 1 SUPPL. 1, p. 23-26 4 p.

Research output: Contribution to journalArticle

Prednimustine
Lomustine
Etoposide
Hodgkin Disease
Survival
46 Citations (Scopus)

Salvage chemotherapy in Hodgkin's disease irradiation failures: Superiority of doxorubicin-containing regimens over MOPP

Santoro, A., Viviani, S., Villarreal, C. J. R., Bonfante, V., Delfino, A., Valagussa, P. & Bonadonna, G., 1986, In : Cancer Treatment Reports. 70, 3, p. 343-348 6 p.

Research output: Contribution to journalArticle

Procarbazine
Mechlorethamine
Vincristine
Prednisone
Hodgkin Disease
1985
15 Citations (Scopus)

Evaluation of semen and pituitary gonadotropin function in men with untreated Hodgkin's disease

Ragni, G., Bestetti, O., Santoro, A., Viviani, S., Di Pietro, R. & De Lauretis, L., 1985, In : Fertility and Sterility. 43, 6, p. 927-930 4 p.

Research output: Contribution to journalArticle

Pituitary Gonadotropins
Semen
Hodgkin Disease
Asthenozoospermia
Oligospermia
303 Citations (Scopus)

Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD

Viviani, S., Santoro, A., Ragni, G., Bonfante, V., Bestetti, O. & Bonadonna, G., 1985, In : European Journal of Cancer and Clinical Oncology. 21, 5, p. 601-605 5 p.

Research output: Contribution to journalArticle

Combination Drug Therapy
Hodgkin Disease
Procarbazine
Mechlorethamine
Azoospermia
5 Citations (Scopus)

Phase II study with amsacrines (m-AMSA and m-AMSA lactate) in refractory lymphomas

Bajetta, E., Buzzoni, R., Viviani, S., Villani, F., Piotti, P., Gasparini, G. & Bonadonna, G., 1985, In : Cancer Treatment Reports. 69, 9, p. 965-969 5 p.

Research output: Contribution to journalArticle

Amsacrine
Lactic Acid
Lymphoma
Hodgkin Disease
Non-Hodgkin's Lymphoma
6 Citations (Scopus)
Vindesine
Lomustine
Etoposide
Cisplatin
Melanoma
32 Citations (Scopus)

Third-line salvage chemotherapy in Hodgkin's disease

Bonadonna, G., Viviani, S., Valagussa, P., Bonfante, V. & Santoro, A., 1985, In : Seminars in Oncology. 12, 1 SUPPL. 2, p. 23-25 3 p.

Research output: Contribution to journalArticle

Prednimustine
Lomustine
Etoposide
Hodgkin Disease
Drug Therapy
1984
9 Citations (Scopus)
Non-Hodgkin's Lymphoma
Survival
Prednisone
Lymphoma, Large B-Cell, Diffuse
Bleomycin
38 Citations (Scopus)

Gonadal damage in Hodgkin's disease from cancer chemotherapeutic regimens

Bonadonna, G., Santoro, A. & Viviani, S., 1984, In : Archives of Toxicology. 55, SUPPL. 7, p. 140-145 6 p.

Research output: Contribution to journalArticle

Chemotherapy
Hodgkin Disease
Procarbazine
Drug Therapy
Alkylating Agents

Risultati della chemioterapia nei sarcomi dei tessuti molli d'adulto.

Translated title of the contribution: Results of chemotherapy of soft tissue sarcoma in adultsSantoro, A. & Viviani, S., Nov 1984, In : Radiologia Medica. 70, 11, p. 893-895 3 p.

Research output: Contribution to journalArticle

1983
20 Citations (Scopus)

Non-Hodgkin's lymphomas of Waldeyer's ring.

Bajetta, E., Buzzoni, R., Rilke, F., Valagussa, P., Rovej, R., Viviani, S., Lattuada, A., Banfi, A. & Bonadonna, G., Apr 30 1983, In : Tumori. 69, 2, p. 129-136 8 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Palatine Tonsil
Stomach
Radiotherapy
Recurrence